Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- IFPW General Membership Meeting Held in Monte Carlo
September 23, 2002
- REGULATORY NEWS IN BRIEF
September 23, 2002
- Banyu to Boost Its Sales to \300 Bil. by FY2007: Mr Nagasaka
September 23, 2002
- Cancer Risk Increases with Level of Alcohol Consumption: Korosho Report
September 23, 2002
- Korosho Calls For Closer Management of Radiation Devices
September 23, 2002
- Makers Called On to Take Measures to Prevent Drug Misuse
September 23, 2002
- BI, Pfizer to Start Long-term Clinical Trial for Spiriva
September 23, 2002
- Sysmex Doubles Production Capacity
September 23, 2002
- Clinical Trials of Imported Drugs Unapproved in Japan to Be Stimulated
September 23, 2002
- BULLETIN
September 23, 2002
- BUSINESS NEWS IN BRIEF
September 16, 2002
- JPMA President Calls For Joint Effort of Industry, Government Based on Vision
September 16, 2002
- Kuraya Sanseido Passive on Promoting Generics
September 16, 2002
- SMONA Expands Business, Organization in the 2nd Year
September 16, 2002
- WEBSITE NEWS
September 16, 2002
- NEW PRODUCTS
September 16, 2002
- Draft Report on Activities of SMO Prepared: Korosho Council
September 16, 2002
- Korosho Specifies Ordinances to Follow PAL Amendment
September 16, 2002
- No Abnormalities in Health Checks Decreasing: JHA Report
September 16, 2002
- LDP to Consider "Independent Insurance" or "Age-risk Adjusted Program" for Elderly
September 16, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…